Driven by Love: Mothers on a Mission Ensure the Neurodiverse Are Counted Among Christ’s Flock

Valuable Information on ADHD From the Scientific Community: Takeaways from the 2023 International Conference on ADHD

The Unmet Need for Mental Health Services is Even Worse for Children Who Are Racial and Ethnic Minorities

Shortage of Adderall and other ADHD drugs expected to last through 2024, despite federal attempts to fix it

Longer Use of ADHD Meds May Boost Heart Risk — Observational data suggest particular risk for hypertension and arterial disease

People taking ADHD medications should closely monitor their heart health, study suggests

Can’t Think, Can’t Remember: More Americans Say They’re in a Cognitive Fog

ADHD drugs delay bone healing in children, UB researchers report

Substituting ADHD Medications During the Stimulant Shortage

Annual International Conference on ADHD Hosted by CHADD, ADDA and ACO Provides Practical Support and Guidance for the ADHD Community

Adderall makers agree to increase production: DEA

Underdiagnosed and undertreated, young Black males with ADHD get left behind

William Pelham Jr., a groundbreaking researcher in children’s ADHD, dies at 75 in Miami

Youngest children in class with ADHD as likely to keep diagnosis in adulthood as older pupils, find scientists

New genes linked to ADHD identified, potentially paving the way for new treatments

New distractibility ‘d factor’ may be linked with ADHD

Study challenges link between low birth weight and childhood neurodevelopmental issues

A Revolutionary Peek at the Noradrenaline System

Adults with ADHD are at increased risk for developing dementia

Craig Surman, MD: Sleep Drug Solriamfetol Can Effectively Treat ADHD

Overtalking may signal a mental health condition

Narcolepsy Drug Might Be New Treatment Option for ADHD

The A.D.H.D. Drug Shortage Is Causing Real Pain (Opinion)

ADHD Appears Underdiagnosed in Patients at a Pediatric Headache Clinic

FDA Takes Steps to Advance the Development of Novel Therapies for Stimulant Use Disorders

DEA Loosens ADHD Drug Production Controls Amid Shortage

Study: Prevalence of ADHD was steady during the pandemic

Scientists find new evidence to explain how we pay attention

DEA Gets an Earful About Telehealth Prescribing of Controlled Substances — Proposed in-person visit requirements raises concern for psychiatry groups

Signs you might be struggling with emotional dysregulation, according to 2 therapists

Study shows nearly 300% increase in ADHD medication errors

People over 50 with ADHD ‘overlooked’ for diagnosis and treatment, say experts

Positive Top-Line Phase 3 Data on Novel ADHD Treatment, CTx-1301

ADHD medications still in shortage, frustrating patients and doctors

Understanding the unique challenges of adult ADHD

ADHD Drug Shortages Worsen as Makers Say Production Is Maxed Out